These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9202670)
21. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181 [TBL] [Abstract][Full Text] [Related]
22. K-ras mutation in focal proliferative lesions of human pancreas. Terhune PG; Phifer DM; Tosteson TD; Longnecker DS Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496 [TBL] [Abstract][Full Text] [Related]
23. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339 [TBL] [Abstract][Full Text] [Related]
25. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680 [TBL] [Abstract][Full Text] [Related]
26. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591 [TBL] [Abstract][Full Text] [Related]
27. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Traverse S; Cohen P; Paterson H; Marshall C; Rapp U; Grand RJ Oncogene; 1993 Nov; 8(11):3175-81. PubMed ID: 8414521 [TBL] [Abstract][Full Text] [Related]
28. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. Saez R; Chan AM; Miki T; Aaronson SA Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601 [TBL] [Abstract][Full Text] [Related]
29. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene. Li Y; White R Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528 [TBL] [Abstract][Full Text] [Related]
30. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue]. Cui Q; Wang Z; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165 [TBL] [Abstract][Full Text] [Related]
31. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876 [TBL] [Abstract][Full Text] [Related]
32. Mutations that abolish the ability of Ha-Ras to associate with Raf-1. Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000 [TBL] [Abstract][Full Text] [Related]
33. Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas. Gonzalez-Cadavid NF; Zhou D; Battifora H; Bar-Eli M; Cline MJ Oncogene; 1989 Sep; 4(9):1137-40. PubMed ID: 2674856 [TBL] [Abstract][Full Text] [Related]
34. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer. Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240 [TBL] [Abstract][Full Text] [Related]
35. Correlation of constitutive activation of raf-1 with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells. Patel BK; Ray S; Whiteside TL; Kasid U Mol Carcinog; 1997 Jan; 18(1):1-6. PubMed ID: 9022807 [TBL] [Abstract][Full Text] [Related]
36. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323 [TBL] [Abstract][Full Text] [Related]
37. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Moskaluk CA; Hruban RH; Kern SE Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111 [TBL] [Abstract][Full Text] [Related]
38. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay. Santiago FS; Todd AV; Hawkins NJ; Ward RL Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712 [TBL] [Abstract][Full Text] [Related]
39. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648 [TBL] [Abstract][Full Text] [Related]
40. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression. Yip-Schneider MT; Lin A; Barnard D; Sweeney CJ; Marshall MS Int J Oncol; 1999 Aug; 15(2):271-9. PubMed ID: 10402237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]